Application Insights: Vaccine delivery is projected to be a leading application segment in the global needle-free injectors ...

How will vaccines be prescribed and dispensed ... intranasal, transdermal, and subcutaneous microarray patches. On June 25, 2024, BARDA announced a four-pronged strategy to leverage existing ...

In the early 1950s there were four vaccines routinely used in the United States: diphtheria, tetanus, pertussis, and smallpox. Three of these vaccines (diphtheria, tetanus, and pertussis ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

The global sales of attenuated vaccines are projected to soar, with an estimated worth of USD 5,068.2 million in 2024 and anticipated to reach USD 9,693.9 million by 2034. This growth trajectory ...

These figures demonstrate a larger trend: changing attitudes toward vaccines in the United States. The factors driving this shift are complex and, sometimes, sensitive. To help simplify this topic ...

The global needle-free vaccine injector market is projected to grow significantly, with estimated sales valued at USD 1,844.6 ...

Nov 6 (Reuters) - An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organisations said ...

The global novel vaccine delivery systems market size was US$ 5,429.6 million in 2021. The global novel vaccine delivery systems market is forecast to grow to US$ 11,306.1 million by 2030 by ...